Postpartum Intervention for Mothers With Opioid Use Disorders

This study is looking at an intervention called "Mom Power" for mothers with opioid use disorder (OUD) who have a child aged 5 or less. Mom Power is a program designed to help mothers with their mood and parenting skills. Researchers want to see if this program, delivered virtually (online or by phone), can help reduce drug use and improve mood in mothers with OUD. You may be able to join if you are a mother between 18 and 50 years old, have an OUD diagnosis or are receiving medication-assisted treatment (like buprenorphine or methadone), and can understand English. The study aims to enroll 50 participants, but its current status is unclear.

Study design
This is an interventional study, meaning participants will receive a specific intervention. It plans to enroll 50 participants.
What's involved
Experimental participants will receive virtual Mom Power via phone/internet connection. Control participants will receive mail information and confirmation phone calls.
Compensation
Not stated in the trial record.
Follow-up
The primary endpoints are measured at less than 2 years.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT05614661

Postpartum Intervention for Mothers With Opioid Use Disorders

Recruiting
NAAges 18–50InterventionalTreatment
Stony Brook University
~50 participants
Updated 2024-12-16 on ClinicalTrials.gov
What's tested:Mom Power

At a glance

Recruiting sites
2 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
R61 Milestone 1
Measured over <2 years
+3 more outcomes measured
Opioid Use Disorder
2 sites across 2 states
Michigan1
New York1
  • James E Swain, MD, PhD · PRINCIPAL_INVESTIGATOR · Stony Brook University

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

mothers aged 18-50 from SBU or UM with diagnosis of Opioid Use Disorder (OUD); and/or receiving medication assisted treatment (such as buprenorphine or methadone)
with a child aged 5 or less
able to read, hear and understand English adequately enough to provide informed consent
  • R61 Milestone 1<2 years

    To recruit at least N = 50 participants in 11.25 months for the expanded number in the R33

  • R61 Milestone 2<2 years

    To end with 80% of mothers in the MP condition attending \>=80% of sessions

  • R61 Milestone 3<2 years

    To end with \>=70% yielding satisfactory pre- and post-intervention ERP and fMRI data

  • R61 Milestone 4<2 years

    To show that vMP for OUD significantly affects ERP (LPP and N170) and drug craving, mood, and parenting stress (P\<0.05)